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Diagnostic tests
Scanning for melanoma
Elisabeth M Wurm, Research Assistant, and H Peter Soyer, Chair, Dermatology Research Centre, 
The University of Queensland, School of Medicine, Princess Alexandra Hospital, Brisbane
Summary
Non-invasive diagnostic tools aim at increasing 
accuracy of melanoma diagnosis. Clinical naked 
eye observation in combination with dermoscopy 
can be regarded as the practical reference 
standard to identify lesions for histopathological 
evaluation. Pigmented lesions need to be 
evaluated in the context of patient history to 
identify risk factors for melanoma, followed by a 
dermoscopically-aided entire skin examination. 
Patients with identified risk factors should be 
further examined. Total body photography 
is widely used in the follow-up of high-risk 
patients (particularly those with numerous and 
dysplastic naevi) and can be coupled with digital 
dermoscopy or videodermoscopy. New non-
invasive diagnostic aids comprise multispectral 
image analysis, reflectance confocal microscopy 
and computer assisted diagnostic systems. Also, 
molecular profiling of lesions is an emerging 
technique under investigation for melanoma 
diagnosis.
Key words: dermoscopy, total body photography, reflectance 
confocal microscopy.
(Aust Prescr 2010;33:150–5)
Introduction
Early detection of melanoma remains a significant challenge 
for clinicians. The critical issue is to remove all lesions that 
may be malignant while minimising the excision rate of 
harmless benign lesions. Since naked eye examination has a 
comparatively low sensitivity in melanoma detection, additional 
non-invasive diagnostic tools such as dermoscopy are being 
used in daily practice and have improved the sensitivity of 
diagnosis when applied by experts.1–3 The current diagnostic 
gold standard is visual inspection with dermoscopy followed 
by histopathological examination as required. A high number 
of unnecessary surgical procedures are still performed. 
A recent report dealing with primary skin cancer care in 
Queensland showed that 19.6 pigmented lesions are excised per 
melanoma.4
Several new non-invasive diagnostic tools aimed at increasing 
the accuracy of skin cancer diagnosis and thereby minimising 
unnecessary surgical procedures have emerged in recent years 
(Table 1). This expanding choice of diagnostic tools may cause 
confusion among doctors about what they are and how they 
can be used. Most systems offer a combination of diagnostic 
methods which may add to the uncertainty. 
Clinical examination with visual inspection
A patient history to identify risk factors for melanoma as well 
as a full body examination aided by dermoscopy should be 
performed for every new patient. Since further evaluation is 
time-consuming, those individuals at risk, as well as lesions that 
are considered as atypical or suspicious, should be identified. A 
detailed history should include: 
n age and sex
n personal history of melanoma or non-melanoma skin cancer
n family history of melanoma
n number of naevi
n presence of atypical or dysplastic naevi
n skin type
n tanning habits
n response to sun exposure and evidence of skin damage from 
the sun.5,6
An inspection of the entire cutaneous surface should include the 
axillae, groin, the interdigital webs of the hands and feet, the 
nail apparatus and the scalp. 
The ABCD acronym – Asymmetry, Border irregularity, Colour 
variegation, and large Diameter – supplemented with an E 
for Evolution, represents the clinical guideline for melanoma 
diagnosis. In contrast, the EFG acronym – Elevated, Firm and 
Growing progressively – is more appropriate for nodular 
melanomas that often have a more subtle clinical appearance.7 
On physical examination, new and changing naevi should be 
detected as well as any 'ugly ducklings', that is, lesions that are 
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dissimilar to the rest. 
However, any one single visual inspection fails to detect small 
melanomas and amelanotic melanomas. Thus for high-risk 
individuals, six-monthly full cutaneous examinations supported 
by total body photography and dermoscopy as well as patient 
education for self-examination have been recommended by 
Australian guidelines.8
Total body photography
Total body photography is widely used in the follow-up of  
high-risk patients, particularly those with numerous and dysplastic 
naevi. The technique can be performed with any camera, and 
a standard digital camera that provides good image quality for 
digital sectional body images is the most cost-effective option. 
To document nearly the entire body surface the patient should 
assume standardised positions under good light conditions. 
Images should be taken of the face, neck, area behind the ears, 
scalp (in bald individuals), anterior and posterior trunk, and the 
extremities (including palms and soles). Subsequent new or 
changing lesions that may be indicative of melanoma can be 
Table 1
Comparison of mole scanning methods
Method Facts Advantages Main disadvantages
Visual inspection ABCDE* rule is the usual 
clinical guide for most 
lesions, but EFG† is more 
appropriate for nodular 
lesions
Easy to perform Limited sensitivity in 
melanoma diagnosis
Total baseline photography Digital imaging in 
standardised positions
Nearly whole skin surface 
visualised
Identification of 'ugly 
ducklings'
Identification of new or 
evolving lesions
Only gives macroscopic 
information
Handheld dermoscopy Visualisation of subsurface 
anatomic structures of 
epidermis and upper dermis
Dermoscopes with polarised 
and non-polarised light are 
available
Well-established criteria
Increases diagnostic 
sensitivity without 
diminishing specificity, when 
performed by specialists
Requires specialised training
Sequential dermoscopic 
follow-up
Automated diagnosis/ 
teledermoscopy and 
combination with total 
baseline photography 
possible
Only preselected lesions 
can be compared 
dermoscopically
Not suitable for nodular 
lesions
Multispectral image analysis Light reflected in different 
skin depths is collected and 
analysed
Visual information of deeper 
skin layer compared with 
dermoscopy
Automated diagnosis 
possible
Needs further evaluation in 
clinical trials
High-frequency ultrasound 
and optical coherence 
tomography
Vertical imaging of the skin Monitoring of topical 
treatment possible
To date, not diagnostic aids
Reflectance confocal 
microscopy
Horizontal imaging of the 
skin with laser light that 
causes no tissue damage
Melanin/melanocytes are a 
strong source of contrast
Quasi-histological resolution 
offers in vivo biopsy, 
monitoring of treatment, pre-
surgical margin assessment
Requires specialised training
Limited imaging depth
To date, mainly used for 
research
Multiphoton laser scanning 
microscopy
Visualisation of cellular and 
subcellular structures
To date, mainly used for 
research
*     Asymmetry, Border irregularity, Colour variegation, and large Diameter, supplemented with an E for Evolution 
†     Elevated, Firm and Growing progressively
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recognised in follow-up examinations by comparing the images 
with the patient's skin. Specific digital skin photography systems 
are available which facilitate standardisation of imaging and 
data storage (Table 2). 
Total body photography has been reported to enable melanoma 
detection at an early stage.9 However, small changes in naevi 
will probably be missed when only applying macroscopic 
imaging. A combined dermoscopic and total body photography 
approach is therefore recommended for patients who have 
atypical moles. Whereas digital dermoscopic images can 
Table 2
Overview of various mole scanning devices
Device Comments
EpiScope 
www.welchallyn.com •
Handheld device
Dermatoscope Delta 
www.heine.com •
Handheld device
DermoGenius basic 
www.biocam.de •
Handheld device
DermLite Platinum 
www.dermlite.com •
Handheld device
Molemax 
www.equipmed.com • • • • •
Imaging system
Fotofinder  
www.fotofinder.de • • • • • •
Imaging system
DermoGenius Ultra 
www.biocam.de • • • •
Imaging system
MicroDerm 
www.visiomedag.com • • • •
Imaging system
Dermoscopix 
www.dermoscopix.com • • •
Imaging software 
Melanoscan 
www.melanoscan.com •
Imaging system
MoleMap 
www.molemap.net.au • • • •
Imaging and patient history 
done by trained nurse
Db-Dermo Mips 
www.skinlesions.net • •
Automated diagnosis based on 
dermoscopy
MelaFind 
www.eosciences.com •
Automated diagnosis based on 
multispectral image analysis
The features of the devices that are, in our estimation, most important are indicated by dots. For further detailed information 
on the devices and recent developments, follow the web links.
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be obtained with dermoscopic lenses that can be attached 
easily to most commercially available cameras, various skin 
imaging devices offer a combination of total body photography 
and dermoscopy (Table 2). Some devices are also able to 
automatically compare two overview images and highlight new 
and changing lesions on the screen, though large-scale clinical 
studies of a high-risk population are needed to validate these 
findings. 
Dermoscopy 
Dermoscopy, also known as dermatoscopy or epiluminescence 
microscopy, has been widely adopted into everyday clinical 
use. It enables visualisation of subsurface anatomic structures 
of the epidermis and upper dermis. A dermoscope consists 
of a light source and a magnifying lens. While non-polarised 
dermoscopes require operation with an immersion medium, 
such as oil or alcohol, dermoscopes with polarised light do not. 
Digital dermoscopy or videodermoscopy is also now widely 
used. As well as easy storage and retrieval, digital dermoscopic 
and clinical images can be sent electronically. This is called 
teledermatology or teledermoscopy (Table 1).
Numerous diagnostic algorithms have been proposed to 
assess a lesion including pattern analysis, ABCD rule, Menzies 
method, seven-point checklist and three-point checklist. All 
these algorithms have been proven to be of high specificity and 
sensitivity in the diagnosis of melanoma. The choice of which 
one to use should be made upon personal preferences.*
Dermoscopy, when performed by specialists, increases 
diagnostic sensitivity without diminishing specificity and has 
been shown to decrease unnecessary excisions.1–3,10 Two 
meta-analyses on studies published before 2000 verified that 
dermoscopy is superior to naked eye examination when used 
by experts.1,2
Another study reported that even a one-day tutorial on 
dermoscopy can improve the ability of primary care physicians 
to correctly refer individuals with suspicious lesions to a skin 
lesion clinic.11 A recent meta-analysis focused exclusively on 
studies that were performed in a clinical setting and found 
the relative diagnostic odds ratio (a measure for diagnostic 
accuracy) was 15.6 for dermoscopy compared to naked eye 
examination.3 This strong scientific evidence indicates that 
dermoscopy is presently the practical reference standard for 
non-invasive diagnosis of melanoma. 
Follow-up examinations
Due to the impracticability of removing all lesions, follow-up is 
crucial so that melanomas which lack atypical features at the 
first visit are not missed. Suspicious lesions can be monitored 
by serial dermoscopic and macroscopic imaging. Digital 
dermoscopic (and clinical) images are taken and linked to the 
body site via a computer. At the follow-up visit, the same lesion 
is photographed again for comparison. This is especially useful 
for patients with multiple lesions, and reportedly improves 
sensitivity in melanoma diagnosis.3,12 Re-examination after 
three months with subsequent follow-up visits every 6–12 
months seems to be a useful strategy. For individuals with 
familial atypical multiple mole and melanoma syndrome,  
follow-up every three months is recommended.13
A major disadvantage of the method is, however, that only 
preselected lesions are monitored, whereas changes in a 
previously unsuspicious lesion or a de novo lesion might be 
missed. Follow-up should never be performed in nodular 
lesions, because if they are malignant they tend to grow faster 
than other melanoma types. Even short delays in treatment 
might increase the risk of a poor prognosis.
Teledermatology
Digital dermoscopic imaging enables primary care physicians to 
forward dermoscopic images (together with clinical information 
and macroscopic images) to specialists for a second opinion.14 
Studies have shown good agreement between face-to-face 
diagnosis and diagnosis based on digital images.15,16 This is 
especially useful in remote areas, where referral is associated 
with considerable healthcare costs, and time for the patient. 
Modern skin imaging devices combine dermoscopy and 
total body photography with teledermoscopic networks and 
computer-assisted automated diagnosis (Table 2). The company 
MoleMap, established by dermatologists, for example, offers a 
system in which a detailed examination followed by total body 
photography and comprehensive dermoscopic image capture is 
obtained by a specifically trained nurse. This information is then 
sent electronically to a dermatologist for expert analysis. 
Multispectral image analysis
Multispectral imaging relies on the principle that light of 
different wavelengths, of the visible and infrared spectrum, 
penetrates the skin to different depths. When coupled with 
computer-based analysis, certain features not visible in 
macroscopic and dermoscopic analysis can be visualised. 
Other non-invasive imaging tools 
High-frequency ultrasound
High-frequency ultrasound provides a vertical image of the skin 
based on its different acoustic properties. However, because 
of the limited resolution, ultrasound alone is not a reliable 
diagnostic aid. It is more appropriately used for preoperative 
management in dermatology, for example, in assessing tumour 
thickness and vascularity.
* A detailed description of these algorithms can be found at 
www.dermoscopy.org/consensus/tutorial.asp
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Optical coherence tomography
Optical coherence tomography is comparable to ultrasound, 
however it uses light instead of sound waves. It has better 
resolution than ultrasound but only penetrates to a depth of 
up to 1 mm, which approximately corresponds to the reticular 
dermis. 
The resolution of optical coherence tomography does not 
reach the capabilities of reflectance confocal microscopy or 
histopathology, however cellular details can be viewed with the 
more modern devices. Although there are studies regarding 
the various features of skin cancer, reports of the diagnostic 
accuracy of optical coherence tomography are lacking. It seems 
that this technique might also play a role in other skin diseases 
in the future, such as contact dermatitis, psoriasis and bullous 
diseases, as well as monitoring of topical treatment.17
Reflectance confocal microscopy
Confocal laser scanning microscopy can be operated in 
fluorescence or reflectance mode, but reflectance confocal 
microscopy is more suitable for clinical applications. Reflectance 
confocal microscopy allows visualisation of the epidermis and 
papillary dermis at a quasi-histological resolution. Horizontal 
sections of a lesion can be scanned and viewed using a near-
infrared laser. This method is ideally suited for melanoma 
diagnosis as melanin provides strong contrast and is easily 
visualised. Diagnostic algorithms for melanoma detection have 
been proposed and show improved diagnostic specificity and 
sensitivity.18–20 Furthermore, a glossary of terms commonly 
used in reflectance confocal microscopy has been published.21 
This type of microscopy has also been used in non-melanoma 
skin cancer, Mohs surgery, in vivo surgical margin assessment 
and in follow-up of response to topical treatment. However, 
large-scale clinical studies are needed to assess the method's 
full clinical potential.
Multiphoton laser scanning microscopy
Multiphoton laser scanning microscopy works with a near-
infrared laser beam which excites endogenous fluorophores. 
Nicotinamide adenosine dinucleotide phosphate (NADPH) is the 
primary source of autofluorescence. Like reflectance confocal 
microscopy, the multiphoton laser scanning microscopy 
provides horizontal sections of the skin allowing visualisation of 
cellular and subcellular structures. To date, it is mainly used as a 
research tool, rather than clinically.
Computer-assisted diagnosis
Automated diagnostic systems extract and analyse features 
of skin lesions and give a diagnosis. They have been shown 
to reach comparable levels of diagnostic specificity and 
sensitivity to that of expert dermatologists.22 To date, a few fully 
automated systems are available, some of which are integrated 
in the software of videodermoscopy devices (Table 2). MelaFind 
uses multispectral imaging information from dermoscopic 
images. The MelaFind system is currently in the final stages 
of being granted US Food and Drug Administration approval 
and is anticipated to be available in the not too distant future. 
There is a tendency of these tools to over-diagnose melanoma. 
Further studies are required to assess the impact of automated 
instruments against human performance in the clinical field.
Molecular profiling
Molecular profiling is an emerging technique in melanoma 
diagnosis. A method that analyses RNA acquired from tape 
stripping of a suspicious melanocytic lesion is currently under 
investigation. 
Conclusion
Although newer imaging techniques hold great promise, they 
cannot replace visual inspection and patient examination. 
Clinical naked eye observation in combination with dermoscopy 
can be regarded as the practical reference standard to identify 
lesions for excision. Histopathological analysis of lesions 
remains the gold standard in skin cancer diagnosis. 
It is important to emphasise that pigmented lesions need to be 
evaluated in the context of a patient's entire skin examination. 
Although a general practitioner may easily make the decision 
to excise a suspicious lesion, there are a few clinical situations 
where a dermatologist's advice should be sought and further 
evaluation be performed. These include high-risk patients 
with multiple (atypical) naevi or naevi on specific anatomical 
locations such as palms, soles of the feet and under the nails, or 
on the genitals. 
New non-invasive imaging techniques have great potential for 
monitoring lesion growth and response to treatment, as well as 
true margin assessment before surgery.
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Self-test questions
The following statements are either true or false  
(answers on page 163)
3. All patients with suspicious skin lesions need a full 
body examination at their first visit.
4. The ABCD rule is the appropriate clinical guide for 
assessing nodular lesions.
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Book review
bodies to which the profession is attached, and rules relating to 
registration as a pharmacist in the UK. 
The chapter dedicated to professional conduct is limited 
in scope, by the authors' own admission, to the Royal 
Pharmaceutical Society's Code of Ethics. It does however 
clarify to the reader the exact status of the code and how 
pharmacists are bound by criminal, administrative and civil 
law as well as by the Code. In practical terms, the reader is 
taken through the principles and short explanations in clear 
unambiguous language, with references for further reading for 
those interested in more in-depth analyses of ethical principles 
underlying the Code.
The chapter on fitness to practise is of particular interest to 
those following the current roll-out of new legislation regarding 
pharmacy and other healthcare professions in Australia. The 
authors explain in detail the role of the various committees set 
up to address the diverse types and levels of misconduct and 
impairment, providing examples to elucidate stratification of 
jurisdiction and powers of these committees.
Although focused on the UK, this book is a valuable resource for 
those involved or interested in the legal and ethical framework 
of pharmacy practice outside Australia. It is an illuminating and 
helpful resource, not only because there are many similarities 
and universal practices in the pharmacy professions of western 
countries, but also in light of the current changes in Australian 
legislation. 
Dale and Applebe's Pharmacy Law and Ethics. 
9th ed. Applebe G, wingfield J.
London: Pharmaceutical Press; 2009. 553 pages.
Betty Chaar, Lecturer, Pharmacy Practice and Professional Ethics 
in Pharmacy, Faculty of Pharmacy, The University of Sydney
This very thorough examination of all legal aspects of the 
practice of pharmacy in the United Kingdom is the ninth edition 
of a popular text, widely used as a resource for pharmacists and 
in the training of future pharmacists in the UK. It is perhaps of 
less relevance to Australia, except that it could serve as a superb 
model for a similar text prepared in the Australian context of 
legal and ethical frameworks.
The book has benefited from years of revision, but also updates 
the reader about the 'plethora of legal changes that have been 
promulgated in recent years'. It is thoroughly researched, well 
indexed and is presented in a user-friendly style of headings 
and subheadings, with the added convenience of a summary 
at the end of each chapter, further reading suggestions and 
websites. The examples given to clarify complex issues are 
particularly useful to practitioners. Comparative analyses with 
other professions are also illuminating.
The majority of the 27 chapters are dedicated to explanation and 
examples of cases relating to various sections of the Medicines 
Act 1968. There are chapters about miscellaneous legislation 
relevant to the profession, explanation of the roles of various 
